Developing a new targeted oncology therapy?
Learn more about multi-biomarker NGS assays
The Life Technologies™ Clinical Services Lab
Our CLIA-certified, CAP-accredited clinical services lab facility is designed to help pharma and clinicians find comprehensive, accurate answers. We specialize in developing oncology molecular assays for pharmaceutical customers with experience in small or challenging samples. Our lab offers a comprehensive end-to-end oncology workflow, including: histology, pathology, FISH, qPCR, Sanger sequencing, and next-generation sequencing (NGS).
Looking for an optimal therapy for NSCLC?
Get the Pervenio™ Lung NGS assay
Accelerate CDx development
Get a comprehensive view of targets
- From clinical trial assay to IVD development
- Multiple technologies to assess biomarker needs
Profile small or challenging samples
Understand the genetic make-up of your patient's tumor
- Optimized protocol to address low tumor content and low DNA input
- Fast turnaround time
* "Quantity not sufficient" samples for the period Mar. 1–Sep. 30, 2014.